AdvanSource Biomaterials

AdvanSource Biomaterials is an ISO certified materials technology company, specializing in medical grade materials for long and short term applications. The Company's materials are USP Class VI and are available in both standard as well as custom formulations - offering tailored mechanical characteristics in order to enhance and optimize device design and functionality. AdvanSource Biomaterials develops innovative biomaterials which may be used as structural engineering polymers, co-extrusion layers or as specialized coatings for a wide variety of material substrates.
Company Growth (employees)
Type
Public
HQ
Wilmington, US
Founded
1998
Size (employees)
19 (est)+73%
AdvanSource Biomaterials was founded in 1998 and is headquartered in Wilmington, US

AdvanSource Biomaterials Office Locations

AdvanSource Biomaterials has an office in Wilmington
Wilmington, US (HQ)
235 Andover St

AdvanSource Biomaterials Financials and Metrics

AdvanSource Biomaterials Financials

AdvanSource Biomaterials's revenue was reported to be $2.3 m in FY, 2017
USD

Revenue (Q2, 2018)

702 k

Gross profit (Q2, 2018)

486 k

Gross profit margin (Q2, 2018), %

69%

Net income (Q2, 2018)

(335 k)

EBIT (Q2, 2018)

(239 k)

Market capitalization (31-Oct-2017)

1.8 m

Closing share price (31-Oct-2017)

0.1

Cash (30-Sep-2017)

288 k

EV

1.6 m
AdvanSource Biomaterials's current market capitalization is $1.8 m.
USDFY, 2017

Revenue

2.3 m

Cost of goods sold

853 k

Gross profit

1.4 m

Gross profit Margin, %

63%
USDQ3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q2, 2018

Revenue

685 k621 k1.2 m1 m592 k800 k467 k702 k

Cost of goods sold

168 k228 k322 k305 k242 k259 k174 k216 k

Gross profit

517 k393 k849 k736 k350 k541 k293 k486 k

Gross profit Margin, %

75%63%73%71%59%68%63%69%
USDFY, 2017

Cash

27 k

Inventories

189 k

Current Assets

454 k

PP&E

1.9 m
USDQ3, 2014Q1, 2015Q2, 2018

Cash

108 k133 k288 k

Inventories

378 k150 k1 k

Current Assets

745 k471 k998 k

PP&E

2.2 m2.1 m
    USDFY, 2017

    Net Income

    (509 k)

    Depreciation and Amortization

    57 k

    Accounts Payable

    174 k

    Interest Paid

    349 k
    USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q2, 2018

    Net Income

    41 k(132 k)337 k181 k(111 k)37 k(172 k)(335 k)

    Depreciation and Amortization

    43 k

    Inventories

    1 k

    Accounts Payable

    (84 k)247 k298 k327 k217 k186 k305 k336 k366 k
      USDY, 2017

      EV/EBIT

      -6.7 x

      Revenue/Employee

      36.9 k

      Financial Leverage

      -4.1 x
      Show all financial metrics

      AdvanSource Biomaterials Market Value History

      AdvanSource Biomaterials's Web-traffic and Trends

      AdvanSource Biomaterials Company Life and Culture

      You may also be interested in